Intrathecal Baclofen Therapy for Severe Spastic Hypertonia
Indications and Patient Selection
- Intrathecal baclofen therapy is indicated primarily for severe spastic hypertonia that does not respond to other interventions, including oral antispasticity medications, botulinum toxin injections, and physical modalities, in patients with multiple sclerosis, spinal cord injury, or spinal cord diseases with significant spasticity 1
- Patients who have failed oral baclofen therapy or experience intolerable side effects from oral medications, and those with severe spasticity requiring higher doses than can be tolerated orally, may be considered for intrathecal baclofen therapy 1
- Intrathecal baclofen therapy can be considered as early as 3-6 months after stroke for patients with severe spastic hypertonia refractory to other treatments, according to clinical guidelines supported by the American Heart Association 1, 2
Treatment Approach
- First-line treatments for spasticity include positioning, passive stretching, and range of motion exercises, oral antispasticity medications, targeted botulinum toxin injections, and physical modalities, which should be tried before considering intrathecal baclofen therapy 1
- Intrathecal baclofen therapy should be considered when spasticity is severe and generalized, and the patient has failed or cannot tolerate maximum doses of oral medications, or when spasticity causes significant functional limitations, such as pain, poor skin hygiene, or decreased function 1
Trial and Implantation
- A test dose of intrathecal baclofen should be administered before proceeding with pump implantation, and implantation should only be done if a satisfactory response is observed 1
Complications and Management
- Abrupt cessation of intrathecal baclofen can lead to catastrophic withdrawal syndrome, which can evolve over 1-3 days and may become fulminant if not recognized, with symptoms including increased spasticity, fever, altered mental status, and seizures, and emergency treatment includes resuming intrathecal infusion or high-dose benzodiazepine IV infusion 3
- Higher concentrations of baclofen in the pump may be considered during pandemics or other situations to reduce refill frequency, according to the American Society of Anesthesiologists 3
Maintenance and Monitoring
- Regular pump refills, periodic assessment of efficacy and dose adjustments, monitoring for complications or side effects, and patient education regarding signs of withdrawal or overdose are essential for maintaining effective intrathecal baclofen therapy 1